Design Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Design Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Design Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Design Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $171k | 23k | 7.53 |
| 2025-06-30 | $92k | 27k | 3.37 |
| 2025-03-31 | $127k | 33k | 3.86 |
| 2024-12-31 | $411k | 67k | 6.17 |
| 2024-09-30 | $80k | 15k | 5.38 |
| 2024-06-30 | $45k | 13k | 3.35 |
| 2024-03-31 | $133k | 33k | 4.03 |
| 2023-12-31 | $134k | 50k | 2.65 |
| 2023-09-30 | $43k | 18k | 2.36 |
| 2023-06-30 | $152k | 24k | 6.30 |
| 2023-03-31 | $1.2k | 206 | 5.77 |
| 2022-12-31 | $1.6M | 156k | 10.26 |
| 2022-03-31 | $16k | 998 | 16.03 |
| 2021-12-31 | $999 | 35 | 28.57 |
| 2021-09-30 | $17k | 1.1k | 14.99 |
| 2021-06-30 | $10k | 498 | 20.08 |
| 2021-03-31 | $9.0k | 300 | 30.00 |